I have a broad mix of technical, operational, and general management experiences in high growth environments, spanning start-up founder to mid-cap public stages, addressing markets and serving customers in healthcare and enterprise businesses (supply chain, retail, manufacturing). Most recently I was co-founder and COO of Specific Diagnostics, which sold to bioMerieux for $425 M in 2022. Prior to Specific I was co-founder and COO of iSense for over 4 years. Previously, I joined Symbol Technologies when it was a small company with revenue near $20 M, and held increasing positions, the last one as CTO when revenues were over $2 B, and the company sold to Motorola and for near $4 B and subsequently to Zebra (NASDAQ: ZBRA) in 2014. My interests and record are in building businesses on new products and technologies. Examples include, Specific’s novel solution for determining antibiotic therapy, a unique identification technology at iSense, both using novel sensing tech and machine-learning-based decision algorithms, and at Symbol, creating the first-in-world mobile computer and wearable computer with WiFi, as well as first company to market and early leader in WiFi products.